chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Vaccination site erythema, Vaccination site pain
Clinical narrative: Pain in axillary area; Pain at injection site; redness at injection site; This spontaneous case was reported by an other and describes the occurrence of AXILLARY PAIN (Pain in axillary area), VACCINATION SITE PAIN (Pain at injection site) and VACCINATION SITE ERYTHEMA (redness at injection site) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced AXILLARY PAIN (Pain in axillary area), VACCINATION SITE PAIN (Pain at injection site) and VACCINATION SITE ERYTHEMA (redness at injection site). At the time of the report, AXILLARY PAIN (Pain in axillary area), VACCINATION SITE PAIN (Pain at injection site) and VACCINATION SITE ERYTHEMA (redness at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Pain in extremity, Tenderness
Clinical narrative: pain in arm; stiffness of shoulder/neck; tenderness; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (tenderness), PAIN IN EXTREMITY (pain in arm) and MUSCULOSKELETAL STIFFNESS (stiffness of shoulder/neck) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jan-2021, the patient experienced TENDERNESS (tenderness). On 29-Jan-2021, the patient experienced PAIN IN EXTREMITY (pain in arm) and MUSCULOSKELETAL STIFFNESS (stiffness of shoulder/neck). At the time of the report, TENDERNESS (tenderness), PAIN IN EXTREMITY (pain in arm) and MUSCULOSKELETAL STIFFNESS (stiffness of shoulder/neck) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pain in extremity, Swelling, X-ray
Clinical narrative: swollen gland on neck under jaw on the right side of their neck; swollen gland under the jaw; sore arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (sore arm), SWELLING (swollen gland on neck under jaw on the right side of their neck) and LYMPHADENOPATHY (swollen gland under the jaw) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Breast cosmetic surgery and Dental implant user since an unknown date. Concomitant products included PARACETAMOL (TYLENOL A) and LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) for an unknown indication.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 27-Jan-2021, the patient experienced SWELLING (swollen gland on neck under jaw on the right side of their neck) and LYMPHADENOPATHY (swollen gland under the jaw). On 24-Jan-2021, PAIN IN EXTREMITY (sore arm) had resolved. At the time of the report, SWELLING (swollen gland on neck under jaw on the right side of their neck) and LYMPHADENOPATHY (swollen gland under the jaw) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Jan-2021, X-ray: normal normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness
Clinical narrative: flu-like symptoms; A spontaneous report was received from a Consumer concerning a 64-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events flu-like symptoms.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 20 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot batch: 032L20A) intramuscularly for prophylaxis of COVID-19 infection.  On 22 Jan 2021, the patient experienced the events flu-like symptoms.  Treatment details included Advil  Action taken with mRNA-1273 in response to the events was not reported.   On an unknown date the outcome of events include, flu-like symptoms was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Cough, Fatigue
Clinical narrative: cough; tiredness; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough) and FATIGUE (tiredness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COUGH (cough) and FATIGUE (tiredness). The patient was treated with OXYMETAZOLINE HYDROCHLORIDE (CORICIDIN [OXYMETAZOLINE HYDROCHLORIDE]) at a dose of 1 dosage form and AZITHROMYCIN (Z-PAK) at a dose of 1 dosage form. At the time of the report, COUGH (cough) and FATIGUE (tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported.
Sex: U
Vaccine: COVID19
Symptoms: Headache, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Rash at the injection site; Itching at the injection site; headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash at the injection site), VACCINATION SITE PRURITUS (Itching at the injection site) and HEADACHE (headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNKNOWN) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced VACCINATION SITE RASH (Rash at the injection site), VACCINATION SITE PRURITUS (Itching at the injection site) and HEADACHE (headache). At the time of the report, VACCINATION SITE RASH (Rash at the injection site), VACCINATION SITE PRURITUS (Itching at the injection site) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Injection site pruritus, Pain
Clinical narrative: injection arm itchiness; injection arm redness; injection arm bruising; chills; fatigue; headache; body aches; injection arm sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (injection arm sore), FATIGUE (fatigue), HEADACHE (headache), PAIN (body aches) and CHILLS (chills) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History was provided by the reporter.  Concomitant products included FLUOXETINE and ETHINYLESTRADIOL, NORELGESTROMIN (XULANE) for an unknown indication.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE PAIN (injection arm sore). On 21-Jan-2021, the patient experienced FATIGUE (fatigue), HEADACHE (headache) and PAIN (body aches). On 27-Jan-2021, the patient experienced CHILLS (chills). On 28-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (injection arm redness) and VACCINATION SITE BRUISING (injection arm bruising). On 29-Jan-2021, the patient experienced INJECTION SITE PRURITUS (injection arm itchiness). The patient was treated with ACETAMINOPHEN for Adverse event, at an unspecified dose and frequency. On 25-Jan-2021, FATIGUE (fatigue), HEADACHE (headache) and PAIN (body aches) had resolved. On 26-Jan-2021, VACCINATION SITE PAIN (injection arm sore) had resolved. On 27-Jan-2021, CHILLS (chills) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (injection arm redness), VACCINATION SITE BRUISING (injection arm bruising) and INJECTION SITE PRURITUS (injection arm itchiness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site bruising, Vaccination site erythema, Vaccination site pain
Clinical narrative: injection arm itchiness; injection arm redness; injection arm bruising; chills; fatigue; headache; body aches; injection arm sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (injection arm sore), FATIGUE (fatigue), HEADACHE (headache), PAIN (body aches) and CHILLS (chills) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History was provided by the reporter.  Concomitant products included FLUOXETINE and ETHINYLESTRADIOL, NORELGESTROMIN (XULANE) for an unknown indication.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE PAIN (injection arm sore). On 21-Jan-2021, the patient experienced FATIGUE (fatigue), HEADACHE (headache) and PAIN (body aches). On 27-Jan-2021, the patient experienced CHILLS (chills). On 28-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (injection arm redness) and VACCINATION SITE BRUISING (injection arm bruising). On 29-Jan-2021, the patient experienced INJECTION SITE PRURITUS (injection arm itchiness). The patient was treated with ACETAMINOPHEN for Adverse event, at an unspecified dose and frequency. On 25-Jan-2021, FATIGUE (fatigue), HEADACHE (headache) and PAIN (body aches) had resolved. On 26-Jan-2021, VACCINATION SITE PAIN (injection arm sore) had resolved. On 27-Jan-2021, CHILLS (chills) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (injection arm redness), VACCINATION SITE BRUISING (injection arm bruising) and INJECTION SITE PRURITUS (injection arm itchiness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Very sore left deltoid at injection site; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE PAIN (Very sore left deltoid at injection site) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L2(or Z)0A) for COVID-19 vaccination.     No Medical History was provided by the reporter.  Concurrent medical conditions included Sulfonamide allergy.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Very sore left deltoid at injection site). At the time of the report, VACCINATION SITE PAIN (Very sore left deltoid at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Hypoaesthesia oral, Lip disorder
Clinical narrative: numbness in the lower lip; felt like having ants (like "hormigas"); the lip stayed down, couldn't lift it; This spontaneous case was reported by a patient and describes the occurrence of   in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       On 25-Jan-2021 the patient experienced numbness in their lower lip 30 min to an hour after the shot. felt like having ants (like hormigas), the lip stayed down, couldn't lift it. It was just a little bit, now is 90% already in its place. Treatment of the event was not reported.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: My arm hurt a little bit.; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (My arm hurt a little bit.) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNKNOWN) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced PAIN IN EXTREMITY (My arm hurt a little bit.). At the time of the report, PAIN IN EXTREMITY (My arm hurt a little bit.) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided. Treatment details were not provided; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Influenza like illness, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: flu-like symptoms; chills; arm started swelling up; real red; very sore; had a lot of itch; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE SWELLING (arm started swelling up), VACCINATION SITE ERYTHEMA (real red), VACCINATION SITE PAIN (very sore), VACCINATION SITE PRURITUS (had a lot of itch) and INFLUENZA LIKE ILLNESS (flu-like symptoms) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029120A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by reporter.  Concomitant products included CETIRIZINE for Allergy, LISINOPRIL, ROSUVASTATIN CALCIUM (CRESTOR) and POTASSIUM for an unknown indication.   On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced VACCINATION SITE SWELLING (arm started swelling up), VACCINATION SITE ERYTHEMA (real red), VACCINATION SITE PAIN (very sore) and VACCINATION SITE PRURITUS (had a lot of itch). On 26-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms) and CHILLS (chills). The patient was treated with ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) at a dose of 325 milligram. At the time of the report, VACCINATION SITE SWELLING (arm started swelling up), VACCINATION SITE ERYTHEMA (real red), VACCINATION SITE PAIN (very sore), VACCINATION SITE PRURITUS (had a lot of itch), INFLUENZA LIKE ILLNESS (flu-like symptoms) and CHILLS (chills) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: flu-like symptoms; chills; arm started swelling up; real red; very sore; had a lot of itch; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE SWELLING (arm started swelling up), VACCINATION SITE ERYTHEMA (real red), VACCINATION SITE PAIN (very sore), VACCINATION SITE PRURITUS (had a lot of itch) and INFLUENZA LIKE ILLNESS (flu-like symptoms) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029120A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by reporter.  Concomitant products included CETIRIZINE for Allergy, LISINOPRIL, ROSUVASTATIN CALCIUM (CRESTOR) and POTASSIUM for an unknown indication.   On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced VACCINATION SITE SWELLING (arm started swelling up), VACCINATION SITE ERYTHEMA (real red), VACCINATION SITE PAIN (very sore) and VACCINATION SITE PRURITUS (had a lot of itch). On 26-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms) and CHILLS (chills). The patient was treated with ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) at a dose of 325 milligram. At the time of the report, VACCINATION SITE SWELLING (arm started swelling up), VACCINATION SITE ERYTHEMA (real red), VACCINATION SITE PAIN (very sore), VACCINATION SITE PRURITUS (had a lot of itch), INFLUENZA LIKE ILLNESS (flu-like symptoms) and CHILLS (chills) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: pain around the injection site/soreness around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain around the injection site/soreness around the injection site) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), FISH OIL and ERGOCALCIFEROL, RETINOL PALMITATE (VITAMINS A & D) for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced VACCINATION SITE PAIN (pain around the injection site/soreness around the injection site). At the time of the report, VACCINATION SITE PAIN (pain around the injection site/soreness around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Treatment information  provided; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Hyperaesthesia, Lymphadenopathy, Myalgia, Pyrexia
Clinical narrative: very sensitive to the touch; Today I noticed that my armpit is swollen; a slight temperature 99.5F; body aches; This spontaneous case was reported by a consumer and describes the occurrence of HYPERAESTHESIA (very sensitive to the touch), LYMPHADENOPATHY (Today I noticed that my armpit is swollen) and PYREXIA (a slight temperature 99.5F) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, the patient experienced PYREXIA (a slight temperature 99.5F). On 01-Feb-2021, the patient experienced HYPERAESTHESIA (very sensitive to the touch) and LYMPHADENOPATHY (Today I noticed that my armpit is swollen). The patient was treated with PARACETAMOL (TYLENOL) on 29-Jan-2021 for Fever and Myalgia, at an unspecified dose and frequency. On 30-Jan-2021, PYREXIA (a slight temperature 99.5F) had resolved. At the time of the report, HYPERAESTHESIA (very sensitive to the touch) and LYMPHADENOPATHY (Today I noticed that my armpit is swollen) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Jan-2021, Body temperature: 99.5f (Inconclusive) Slight temperature.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Urticaria, Vaccination site movement impairment, Vaccination site pain
Clinical narrative: could not lift injection site arm; large red welt on her neck on the same side where she got the vaccine; chills; njection site arm sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (could not lift injection site arm), URTICARIA (large red welt on her neck on the same side where she got the vaccine), CHILLS (chills) and VACCINATION SITE PAIN (njection site arm sore) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (could not lift injection site arm), URTICARIA (large red welt on her neck on the same side where she got the vaccine), CHILLS (chills) and VACCINATION SITE PAIN (njection site arm sore). At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (could not lift injection site arm), URTICARIA (large red welt on her neck on the same side where she got the vaccine), CHILLS (chills) and VACCINATION SITE PAIN (njection site arm sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: My arm was sore (inj site); This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (My arm was sore (inj site)) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2021, the patient experienced VACCINATION SITE PAIN (My arm was sore (inj site)). At the time of the report, VACCINATION SITE PAIN (My arm was sore (inj site)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache
Clinical narrative: CHILLS; Headache; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (CHILLS), HEADACHE (Headache) and FATIGUE (fatigue) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced CHILLS (CHILLS), HEADACHE (Headache) and FATIGUE (fatigue). The patient was treated with IBUPROFEN ongoing since an unknown date at an unspecified dose and frequency. On 23-Jan-2021, CHILLS (CHILLS), HEADACHE (Headache) and FATIGUE (fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the reported events, a causal relationship cannot be excluded.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Pain in extremity, Pyrexia
Clinical narrative: 101° Temperature; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and PYREXIA (101° Temperature) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     Concurrent medical conditions included Down's syndrome, Celiac disease and Hashimoto's disease. Concomitant products included MELOXICAM and LEVOTHYROXINE for an unknown indication.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 27-Jan-2021, the patient experienced PYREXIA (101° Temperature). At the time of the report, PAIN IN EXTREMITY (Sore arm) and PYREXIA (101° Temperature) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Jan-2021, Body temperature: 101 (Inconclusive) 101° temperature was given..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment generic extra strength 500 mg 2 cap every 6 hours.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Pruritus
Clinical narrative: red ring after 9 days size of a silver dollar; felt like it made them itch; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (red ring after 9 days size of a silver dollar) and PRURITUS (felt like it made them itch) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (red ring after 9 days size of a silver dollar) and PRURITUS (felt like it made them itch). At the time of the report, INJECTION SITE ERYTHEMA (red ring after 9 days size of a silver dollar) and PRURITUS (felt like it made them itch) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant and Treatment medications were not provided.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Vaccination site rash
Clinical narrative: rash on left arm at injection site; itchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (rash on left arm at injection site) and PRURITUS (itchy) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History was provided by the reporter.  Concomitant products included CHOLESTEROL for Cholesterol, VITAMINS NOS for an unknown indication.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 27-Jan-2021, the patient experienced VACCINATION SITE RASH (rash on left arm at injection site) and PRURITUS (itchy). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency and CORTISONE for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE RASH (rash on left arm at injection site) and PRURITUS (itchy) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Patient is currently taking Blood pressure medication.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: Swollen Right Shoulder; This spontaneous case was reported by a patient and describes the occurrence of SWELLING (Swollen Right Shoulder) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced SWELLING (Swollen Right Shoulder). At the time of the report, SWELLING (Swollen Right Shoulder) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.   Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Adverse reaction
Clinical narrative: Reaction; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (Reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (Reaction). At the time of the report, ADVERSE REACTION (Reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided
Sex: M
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: large, oval shape area around the injection site that is swollen; large, oval shape area around the injection site that is red; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE SWELLING (large, oval shape area around the injection site that is swollen) and INJECTION SITE ERYTHEMA (large, oval shape area around the injection site that is red) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced INJECTION SITE SWELLING (large, oval shape area around the injection site that is swollen) and INJECTION SITE ERYTHEMA (large, oval shape area around the injection site that is red). At the time of the report, INJECTION SITE SWELLING (large, oval shape area around the injection site that is swollen) and INJECTION SITE ERYTHEMA (large, oval shape area around the injection site that is red) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.  Treatment medications was not provided by the reporter
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pyrexia
Clinical narrative: fever; chills; body aches; This spontaneous case was reported by a nurse and describes the occurrence of PYREXIA (fever), CHILLS (chills) and MYALGIA (body aches) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LISINOPRIL, INSULIN GLARGINE (LANTUS), METFORMIN and LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced PYREXIA (fever), CHILLS (chills) and MYALGIA (body aches). The patient was treated with PARACETAMOL (TYLENOL) on 22-Jan-2021 for Adverse reaction, at a dose of 1 dosage form and IBUPROFEN on 22-Jan-2021 for Adverse reaction, at a dose of 1 dosage form. On 24-Jan-2021, PYREXIA (fever), CHILLS (chills) and MYALGIA (body aches) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Device connection issue, Underdose
Clinical narrative: Syringe failed and patient didnot received full dose; Patient did not receive the full dose; This spontaneous case was reported by a nurse and describes the occurrence of DEVICE CONNECTION ISSUE (Syringe failed and patient didnot received full dose) and UNDERDOSE (Patient did not receive the full dose) in a 69-year-old female patient who received mRNA-1273 (Moderna CoviD-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna CoviD-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced DEVICE CONNECTION ISSUE (Syringe failed and patient didnot received full dose) and UNDERDOSE (Patient did not receive the full dose). On 27-Jan-2021, DEVICE CONNECTION ISSUE (Syringe failed and patient didnot received full dose) and UNDERDOSE (Patient did not receive the full dose) had resolved.        The action taken with mRNA-1273 (Moderna CoviD-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna CoviD-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported.  Treatment medications was not provided by the reporter; Sender's Comments: This report refers to a case of device connection issue and underdose for mRNA-1273 (lot # unknown) with no associated AEs reported.
Sex: F
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: side effect; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (side effect) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (side effect). At the time of the report, ADVERSE EVENT (side effect) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment information provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: 2 inch red circle around the injection site; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE ERYTHEMA (2 inch red circle around the injection site) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure abnormal.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (2 inch red circle around the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (2 inch red circle around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient's concomitant medication included several unspecified medicines for blood pressure.  Patient did not take any treatment for the symptoms.
Age: 78.0
Sex: U
Vaccine: COVID19
Symptoms: Abdominal discomfort, Dysgeusia, Feeding disorder, Nausea, Vomiting
Clinical narrative: couldn't eat; nauseated; Vomit; sick to the stomach; bitter taste on the mouth; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (sick to the stomach), DYSGEUSIA (bitter taste on the mouth), FEEDING DISORDER (couldn't eat), NAUSEA (nauseated) and VOMITING (Vomit) in a 78-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     The patient's past medical history included Pain (the Shingles vaccine in august and that still has pain) since an unknown date. Previously administered products included for an unreported indication: SHINGRIX and vaccine.    On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced ABDOMINAL DISCOMFORT (sick to the stomach) and DYSGEUSIA (bitter taste on the mouth). On an unknown date, the patient experienced FEEDING DISORDER (couldn't eat), NAUSEA (nauseated) and VOMITING (Vomit). On 27-Jan-2021, DYSGEUSIA (bitter taste on the mouth) had resolved. At the time of the report, ABDOMINAL DISCOMFORT (sick to the stomach), FEEDING DISORDER (couldn't eat), NAUSEA (nauseated) and VOMITING (Vomit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash, Vaccination site warmth
Clinical narrative: injection site warmth; injection site rash; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (injection site warmth) and VACCINATION SITE RASH (injection site rash) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (injection site warmth) and VACCINATION SITE RASH (injection site rash). At the time of the report, VACCINATION SITE WARMTH (injection site warmth) and VACCINATION SITE RASH (injection site rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment information provided.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore Arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore Arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore Arm). At the time of the report, PAIN IN EXTREMITY (Sore Arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment information provided.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Swelling at the injection site; Redness at the injection site; Itchiness at the injection site; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), VACCINATION SITE SWELLING (Swelling at the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site) and VACCINATION SITE PRURITUS (Itchiness at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 24-Jan-2021, the patient experienced VACCINATION SITE SWELLING (Swelling at the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site) and VACCINATION SITE PRURITUS (Itchiness at the injection site). On 20-Jan-2021, PAIN IN EXTREMITY (Sore arm) had resolved. At the time of the report, VACCINATION SITE SWELLING (Swelling at the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site) and VACCINATION SITE PRURITUS (Itchiness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment information provided.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Myalgia, Nausea, Pyrexia
Clinical narrative: Body aches; fever; nausea; pain in injection site; chills; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body aches), PYREXIA (fever), NAUSEA (nausea), VACCINATION SITE PAIN (pain in injection site) and CHILLS (chills) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041l20a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced MYALGIA (Body aches), PYREXIA (fever), NAUSEA (nausea), VACCINATION SITE PAIN (pain in injection site), CHILLS (chills) and FATIGUE (fatigue). At the time of the report, MYALGIA (Body aches), PYREXIA (fever), NAUSEA (nausea), VACCINATION SITE PAIN (pain in injection site), CHILLS (chills) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment information provided.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Body aches; fever; nausea; pain in injection site; chills; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body aches), PYREXIA (fever), NAUSEA (nausea), VACCINATION SITE PAIN (pain in injection site) and CHILLS (chills) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041l20a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced MYALGIA (Body aches), PYREXIA (fever), NAUSEA (nausea), VACCINATION SITE PAIN (pain in injection site), CHILLS (chills) and FATIGUE (fatigue). At the time of the report, MYALGIA (Body aches), PYREXIA (fever), NAUSEA (nausea), VACCINATION SITE PAIN (pain in injection site), CHILLS (chills) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment information provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hypersensitivity, Pyrexia
Clinical narrative: 99°F temperature; allergic gastroesophageal; an "interval" headache; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (allergic gastroesophageal), HEADACHE (an "interval" headache) and PYREXIA (99°F temperature) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     Concomitant products included METFORMIN, INSULIN, Allergies Medication and Gastritis Medication for an unknown indication.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced HYPERSENSITIVITY (allergic gastroesophageal) and HEADACHE (an "interval" headache). On an unknown date, the patient experienced PYREXIA (99°F temperature). At the time of the report, HYPERSENSITIVITY (allergic gastroesophageal), HEADACHE (an "interval" headache) and PYREXIA (99°F temperature) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided.   Reporter did not allow further contact